Literature DB >> 8970212

Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin.

H C Meissner1, R C Welliver, S A Chartrand, D R Fulton, W J Rodriguez, J R Groothuis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8970212     DOI： 10.1097/00006454-199612000-00001

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

1.  Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.

Authors:  N N Dougherty; H C Meissner
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease.

Authors:  H C Meissner; J R Groothuis; W J Rodriguez; R C Welliver; G Hogg; P H Gray; R Loh; E A Simoes; P Sly; A K Miller; A I Nichols; D K Jorkasky; D E Everitt; K A Thompson
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection.

Authors:  A Greenough; S Cox; J Alexander; W Lenney; F Turnbull; S Burgess; P A Chetcuti; N J Shaw; A Woods; J Boorman; S Coles; J Turner
Journal:  Arch Dis Child       Date:  2001-12       Impact factor: 3.791

4.  Respiratory Syncytial Virus: Update on Infection, Treatment, and Prevention.

Authors:  Leonard R. Krilov
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 5.  Viral upper respiratory tract infections in young children with emphasis on acute otitis media.

Authors:  Johanna Nokso-Koivisto; Tapani Hovi; Anne Pitkäranta
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-03-27       Impact factor: 1.675
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.